# Arvind Dasari

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/arvind-dasari/

## Facts

| Field | Value |
| --- | --- |
| Citations | 12,907 |
| Field | Colorectal Cancer Treatments and Studies |
| h-index | 45 |
| i10-index | 120 |
| OpenAlex ID | https://openalex.org/A5016574266 |
| ORCID iD | 0000-0001-5271-9744 |
| Works | 411 |

## Researcher papers

- [Trends in the Incidence, Prevalence, and Survival Outcomes in Patients With Neuroendocrine Tumors in the United States](https://scholariq.org/papers/trends-in-the-incidence-prevalence-and-survival-outcomes-in-patients-with/)
- [Phase II Pilot Study of Vemurafenib in Patients With Metastatic <i>BRAF</i> -Mutated Colorectal Cancer](https://scholariq.org/papers/phase-ii-pilot-study-of-vemurafenib-in-patients-with-metastatic-i-braf-i-mutated/)
- [Disparity of Race Reporting and Representation in Clinical Trials Leading to Cancer Drug Approvals From 2008 to 2018](https://scholariq.org/papers/disparity-of-race-reporting-and-representation-in-clinical-trials-leading-to/)
- [Epidemiology, Incidence, and Prevalence of Neuroendocrine Neoplasms: Are There Global Differences?](https://scholariq.org/papers/epidemiology-incidence-and-prevalence-of-neuroendocrine-neoplasms-are-there/)
- [Frequency of carcinoid syndrome at neuroendocrine tumour diagnosis: a population-based study](https://scholariq.org/papers/frequency-of-carcinoid-syndrome-at-neuroendocrine-tumour-diagnosis-a-population/)
- [ctDNA applications and integration in colorectal cancer: an NCI Colon and Rectal–Anal Task Forces whitepaper](https://scholariq.org/papers/ctdna-applications-and-integration-in-colorectal-cancer-an-nci-colon-and-rectal/)
- [Fruquintinib versus placebo in patients with refractory metastatic colorectal cancer (FRESCO-2): an international, multicentre, randomised, double-blind, phase 3 study](https://scholariq.org/papers/fruquintinib-versus-placebo-in-patients-with-refractory-metastatic-colorectal/)
- [Digital health for optimal supportive care in oncology: benefits, limits, and future perspectives](https://scholariq.org/papers/digital-health-for-optimal-supportive-care-in-oncology-benefits-limits-and/)
- [Classifying Colorectal Cancer by Tumor Location Rather than Sidedness Highlights a Continuum in Mutation Profiles and Consensus Molecular Subtypes](https://scholariq.org/papers/classifying-colorectal-cancer-by-tumor-location-rather-than-sidedness-highlights/)
- [Phase I Study of RO4929097, a Gamma Secretase Inhibitor of Notch Signaling, in Patients With Refractory Metastatic or Locally Advanced Solid Tumors](https://scholariq.org/papers/phase-i-study-of-ro4929097-a-gamma-secretase-inhibitor-of-notch-signaling-in/)
- [The 1, 2, 3, 4 of carcinoid heart disease: Comprehensive cardiovascular imaging is the mainstay of complex surgical treatment (Review)](https://scholariq.org/papers/the-1-2-3-4-of-carcinoid-heart-disease-comprehensive-cardiovascular-imaging-is/)

## Researcher topics

- [Colorectal Cancer Treatments and Studies](https://scholariq.org/topics/colorectal-cancer-treatments-and-studies/)
- [Neuroendocrine Tumor Research Advances](https://scholariq.org/topics/neuroendocrine-tumor-research-advances/)
- [Genetic factors in colorectal cancer](https://scholariq.org/topics/genetic-factors-in-colorectal-cancer/)
- [Lung Cancer Research Studies](https://scholariq.org/topics/lung-cancer-research-studies/)
- [Cancer Genomics and Diagnostics](https://scholariq.org/topics/cancer-genomics-and-diagnostics/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.